Implications for Cancer Treatment and Prevention
Aspirin is a widely available, cheap medication with a well-established safety profile. Its potential to prevent cancer metastasis by activating the immune system could completely change cancer therapy, particularly for patients at high risk of recurrence. One potential application of aspirin is as an adjuvant therapy following surgery or other treatments for early-stage cancer. By preventing the formation of micrometastases, aspirin could reduce the risk of relapse and improve long-term survival.
Another potential application is in combination with immunotherapy. By releasing T-cells from suppression, aspirin could enhance the effectiveness of immunotherapeutic agents, leading to better outcomes for patients with advanced cancer. Dr. Jie Yang, who led the Cambridge study, emphasized the potential for aspirin or other drugs targeting this pathway to be more accessible globally than antibody-based therapies. This has the potential to significantly impact cancer care in low and middle-income countries, where limited access restricts expensive treatments.